Literature DB >> 1764021

Human myocardial cytosolic Ca(2+)-independent phospholipase A2 is modulated by ATP. Concordant ATP-induced alterations in enzyme kinetics and mechanism-based inhibition.

S L Hazen1, R W Gross.   

Abstract

Although phospholipases A2 (PLsA2) have been implicated as enzymic mediators of electrophysiological dysfunction during myocardial ischaemia and reperfusion in man, no information on the regulation of human myocardial PLsA2 is available. We now report that human myocardial cytosolic Ca(2+)-independent PLA2 is modulated by ATP through mechanisms which are independent of protein phosphorylation, since: (1) ATP and its non-hydrolysable analogues reversibly augment the initial rate of crude (but not purified) human myocardial cytosolic PLA2 activity 3-4 fold; (2) ATP and its non-hydrolysable analogues dramatically attenuate the rate of thermal denaturation of human myocardial cytosolic PLA2 activity; (3) ATP and its non-hydrolysable analogues alter the sensitivity of human myocardial cytosolic PLA2 to mechanism-based inhibition by (E)-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one; (4) adenine nucleotide triphosphates are more potent than guanine nucleotide triphosphates in activating and stabilizing human myocardial cytosolic PLA2; (5) adenosine 5'-[beta gamma-methylene]triphosphate is more potent than its guanosine counterpart in protecting an essential thiol residue(s) in human myocardial cytosolic PLA2 from covalent modification by 5,5'-dithiobis-(2-nitrobenzoic acid); and (6) ATP-dependent activation and stabilization of human myocardial cytosolic PLA2 are mediated by a cytosolic protein(s) which can be functionally reconstituted with purified human myocardial cytosolic PLA2 catalytic polypeptide. Collectively these results demonstrate that multiple physical and kinetic properties of human myocardial cytosolic Ca(2+)-independent PLA2 are dramatically influenced by dynamic interactions with ATP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764021      PMCID: PMC1130495          DOI: 10.1042/bj2800581

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.

Authors:  M M Thunnissen; E Ab; K H Kalk; J Drenth; B W Dijkstra; O P Kuipers; R Dijkman; G H de Haas; H M Verheij
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

Review 2.  Receptor-effector coupling by G proteins.

Authors:  L Birnbaumer; J Abramowitz; A M Brown
Journal:  Biochim Biophys Acta       Date:  1990-05-07

Review 3.  Prostaglandins and thromboxanes.

Authors:  B Samuelsson; M Goldyne; E Granström; M Hamberg; S Hammarström; C Malmsten
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

Review 4.  Structure and function of phospholipase A2.

Authors:  H M Verheij; A J Slotboom; G H de Haas
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

5.  Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. Mechanism-based discrimination between calcium-dependent and -independent phospholipases A2.

Authors:  S L Hazen; L A Zupan; R H Weiss; D P Getman; R W Gross
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

6.  Chemical modification of the histidine residue in phospholipase A2 (Naja naja naja). A case of half-site reactivity.

Authors:  M F Roberts; R A Deems; T C Mincey; E A Dennis
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

7.  Reversed-phase high-performance liquid chromatographic separation of molecular species of alkyl ether, vinyl ether, and monoacyl lysophospholipids.

Authors:  M H Creer; R W Gross
Journal:  J Chromatogr       Date:  1985-02-27

8.  Purification and characterization of canine myocardial cytosolic phospholipase A2. A calcium-independent phospholipase with absolute f1-2 regiospecificity for diradyl glycerophospholipids.

Authors:  S L Hazen; R J Stuppy; R W Gross
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

9.  Semi-synthetic approach for the preparation of homogeneous plasmenylethanolamine utilizing phospholipase D from Streptomyces chromofuscus.

Authors:  R A Wolf; R W Gross
Journal:  J Lipid Res       Date:  1985-05       Impact factor: 5.922

10.  Purification of rat liver mitochondrial phospholipase A2.

Authors:  J M De Winter; G M Vianen; H Van den Bosch
Journal:  Biochim Biophys Acta       Date:  1982-08-18
View more
  12 in total

Review 1.  Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

Authors:  A A Farooqui; S I Rapoport; L A Horrocks
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

Review 3.  Phospholipase A2 catalysis and lipid mediator lipidomics.

Authors:  Varnavas D Mouchlis; Edward A Dennis
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-23       Impact factor: 4.698

Review 4.  Eicosanoid signalling pathways in the heart.

Authors:  Christopher M Jenkins; Ari Cedars; Richard W Gross
Journal:  Cardiovasc Res       Date:  2008-12-14       Impact factor: 10.787

Review 5.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

6.  Characterization of calcium-independent cytosolic phospholipase A2 activity in the submucosal regions of rat stomach and small intestine.

Authors:  T Fukushima; G Serrero
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

7.  Purification and characterization of a calcium-independent acidic phospholipase A2 from rat lung.

Authors:  R Wang; C R Dodia; M K Jain; A B Fisher
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

8.  Mechanism-based inhibition of iPLA2β demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibition.

Authors:  Christopher M Jenkins; Jingyue Yang; Richard W Gross
Journal:  Biochemistry       Date:  2013-06-10       Impact factor: 3.162

Review 9.  Membrane and inhibitor interactions of intracellular phospholipases A2.

Authors:  Varnavas D Mouchlis; Edward A Dennis
Journal:  Adv Biol Regul       Date:  2015-12-19

Review 10.  Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction.

Authors:  Ari Cedars; Christopher M Jenkins; David J Mancuso; Richard W Gross
Journal:  J Cardiovasc Pharmacol       Date:  2009-04       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.